- Home
- OUST vs QURE Comparison
OUST vs QURE Comparison
Compare OUST & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUST
- QURE
- Stock Information
- Founded
- OUST 2015
- QURE 1998
- Country
- OUST United States
- QURE Netherlands
- Employees
- OUST N/A
- QURE N/A
- Industry
- OUST Industrial Machinery/Components
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- OUST Technology
- QURE Health Care
- Exchange
- OUST Nasdaq
- QURE Nasdaq
- Market Cap
- OUST 1.1B
- QURE 866.3M
- IPO Year
- OUST N/A
- QURE 2007
- Fundamental
- Price
- OUST $30.92
- QURE $62.13
- Analyst Decision
- OUST Strong Buy
- QURE Strong Buy
- Analyst Count
- OUST 6
- QURE 12
- Target Price
- OUST $23.83
- QURE $69.67
- AVG Volume (30 Days)
- OUST 2.9M
- QURE 7.6M
- Earning Date
- OUST 11-06-2025
- QURE 11-04-2025
- Dividend Yield
- OUST N/A
- QURE N/A
- EPS Growth
- OUST N/A
- QURE N/A
- EPS
- OUST N/A
- QURE N/A
- Revenue
- OUST $125,848,000.00
- QURE $14,337,000.00
- Revenue This Year
- OUST $33.30
- QURE N/A
- Revenue Next Year
- OUST $36.50
- QURE $287.72
- P/E Ratio
- OUST N/A
- QURE N/A
- Revenue Growth
- OUST 26.37
- QURE N/A
- 52 Week Low
- OUST $6.34
- QURE $5.35
- 52 Week High
- OUST $36.25
- QURE $65.12
- Technical
- Relative Strength Index (RSI)
- OUST 52.90
- QURE 78.17
- Support Level
- OUST $27.53
- QURE $59.16
- Resistance Level
- OUST $34.27
- QURE $65.06
- Average True Range (ATR)
- OUST 2.36
- QURE 5.56
- MACD
- OUST -0.05
- QURE 0.92
- Stochastic Oscillator
- OUST 58.02
- QURE 89.51
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.